Located in Saint Jean (31) and created in 2012, Tesalys develops a clean technology for the on-site treatment of biomedical waste with infectious risk (DASRI). Following three years of R&D, the company has been marketing its products since 2014. To date, approximately 250 devices have been installed worldwide. Tesalys devices are aimed at healthcare institutions […] Read more
Founded in 2013, THERANEXUS is a clinical-stage, CEA-derived biopharmaceutical company developing drug candidates for the treatment of nervous system diseases. Thanks to its knowledge of neuroglial interactions, THERANEXUS is a pioneer in the design and combination of approved substances and has a solid and diversified portfolio of assets in clinical phase. This strategy allows the […] Read more